Tyrosine Kinase Inhibitors - Globe Thesis

Keyword [Tyrosine Kinase Inhibitors] Result: 141 - 160 \| Page: 8 of 10
141.	Anti-tumor Mechanism Of Benzoxaine,N-substituted Benzylidene Pyrrolidine Diketone And Indole Amide Compounds
142.	Study On The Changes Of Plasma T790M Gene Mutation After TKI Therapy In Patients With Advanced Non-small Cell Lung Cancer
143.	Design,synthesis And Biological Evaluation Of Novel EGFR Tyrosine Kinase Inhibitors
144.	Clinical Observation Of Xiao Zhen Tang On EGFR-TKIs Related Rash(Yin Deficiency Type) Of Lung Adenocarcinoma
145.	Design,Synthesis And Biological Activity Evaluation Of EGFR Kinase Inhibitors Based On The Side Ring Of [3,2-d] Pyrimidine Compounds
146.	Clinical Significance Of Different BCR/ABL Transcripts And The Transcript Evolution At Relapse In Philadelphia-positive B-ALL In The Era Of Tyrosine Kinase Inhibitors
147.	Comparison Of The Efficacy Between Auto-HSCT And Allo-HSCT Combined With TKIs For Patients With Ph+ALL:A Meta Analysis
148.	The Value Of RDW In The Efficacy And Prognosis Of Newly Diagnosed Chronic Myeloid Leukemia Patients Treated With TKI
149.	Research On Mechanism Of Resistance To Tyrosine Kinase Inhibitors In Chronic Myeloid Leukemia Based On Deep Sequeincng And Multi-omics Approach
150.	Treatment Status Of Chronic Myeloid Leukemia In The Era Of Tyrosine Kinase Inhibitors
151.	The Effect Of Concurrent TP53 Mutations On Clinical Efficacy Of First-generation EGFR-TKIs In Patients With EGFR-mutated Advanced NSCLC
152.	The Prognostic Value Of SII/ALB In EGFR Mutant Advanced Non-small Cell Lung Cancer Treated With EGFR-TKI
153.	Design,Synthesis,and Anti-tumor Evaluation Of Novel Ureas As Vascular Endothelial Growth Factor-2 Receptor Tyrosine Kinase Inhibitors&Pyrrolic Compounds Construction
154.	A Preliminary Study On The Safety And Efficacy Of CD19-targeted Chimeric Antigen Receptor T Cells In The Treatment Of Relapsed/refractory Philadelphia Chromosome Positive Acute B Lymphocytic Leukemia
155.	The Relationship Between NLR & FIB And Prognosis Of Targeted Treatment In Advanced Lung Adenocarcinoma With EGFR Mutation
156.	A Retrospective Analysis Of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors (EGFR-TKIs) With Or Without Chemotherapy For Advanced Lung Adenocarcinoma
157.	Clinical Study Of Rebiopsy In Non-Small Cell Lung Cancer Patients With Acquired Resistance To EGFR Tyrosine Kinase Inhibitors
158.	Pathological Significance And Drug Target Effect Of Aberrant RON And MET Co-overexpression In Pancreatic Cancer
159.	Design,synthesis And Biological Evaluation Of Novel Tyrosine Kinase Inhibitors Of Anti-tumor Drug Resistance
160.	Protective Effect Of PI3K On Cardiotoxicity Induced By Tyrosine Kinase Inhibitors
<<First <Prev Next> Last>> Jump to